Safe Guard Program - Sex Offenders in Community based Treatment




References


Association for the Treatment of Sex Abusers (ATSA). (1997, Feb. 7). Anti-androgen therapy and surgical castration.

Barbaree, H. E., Marshall, W. L., Hudson, S. M. (Eds.) (1993). Juvenile sex offender. New York, N.Y.: Guilford Press.

Berlin, F.S. (1997, Apr. 3). Chemical castration for sex offenders. [Letter to the editor]. New England Journal of Medicine 336(14), 1030.

Berlin, F.S., Menicke, C.F. (1981). Treatment of sex offenders with antiandrogen medication: Conceptualization, review of treatment modalities and preliminary findings. American Journal of Psychiatry, 138, 601-607.

Bishop, D. T. (1996). Community Notification for Release Sex Offenders: 1996 Legislative Update Community Protection Initiative (April, 1996) Update.

Blanchard, G. T. (1995). Difficult connection: Therapeutic relationship in sex offender treatment. Orwell, VT: Safer Society Press.

Bradford, J.M., Pawlak, A. (1987). Sadistic homosexual pedophilia: Treatment with cyproterone acetate: A single case study. Canadian Journal of Psychiatry, 32, 22-33.

Briere, J., Runtz, M. (1989). University males' sexual interest in children: Predicting potential indices of "pedophilia" in a non-forensic sample. Child Abuse & Neglect, Vol. 13, 65-75.

Bureau of Justice Statistics (1996) Criminal victimization 1994. April 1996, 1-2.

Community Protection Initiative Update. (1996, Apr.) Minnesota Session Laws Chapter 408-S.F. No. 2856, Article 5.

Cooper, A. J. (1981). Placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Comprehensive Psychiatry, 22, 458-465.

Cumming, G., Buell, M. (1997). Supervision of the sex offender. Brandon, VT: Safer Society Press.

Department of Justice (Dec 1998). Final guidelines for the Jacob Wetterling crimes against children and sexually violent offenders Registration Act, as amended. Federal Register, Vol. 63, No. 242.

English, K. S., Pullen, S., Jones L. (Eds.) (1996). Managing adult sex offenders: Containment approach. American Probation and Parole Association, Jan 1996.

Freeman-Longo, R., Bays, L. (1990). Who am I and why am I in treatment? A goal workbook for clients in evaluation and beginning treatment. Orwell, VT: Safer Society Press.

Freeman-Longo, R., Blanchard, G. T. (1998). Sexual abuse in america: Epidemic of the 21st century. Brandon VT: Safer Society Press.

Furby, L., Weinrott, M., Blackshaw, L. (1989) Sex offender recidivism: A review. Psychological Bulletin, Vol. 105, No. 1, 3-30.

Gagne, P. (1981). Treatment of sex offenders with medroxyprogesterone acetate. American Journal of Psychiatry, 138, 644-646.

Greenfeld, L. A. (1996). Child victimizers: Violent offenders and their victims. Bureau of Justice Statistics and Office of Juvenile Justice and Delinquency Prevention. March 1996. 1-2.

Hanson, R. K. (1997). The development of a brief actuarial scale for sexual offense recidivism. User Report No. 1997-04. Ottawa: Solicitor General of Canada.

Hanson, R. K. , Bussiere, M. T. (1996). Child molester recidivism. Research Summary. Ottawa Solicitor General Canada. http://www.sgc.gc.ca/epub/corr/e199670/ e199670.htm.

Hawker, P.A., Mayer. W.J. (1981). Medroxyprogesterone acetate treatment for paraphilic sex offenders. In J.R. Hayes, T.K. Roberts, K.S. Solway (Eds.). Violence and the violent individual. New York, N.Y.: S.P. Medical and Scientific Books, 353-373.

Kafka, M. (1994). Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: An open trial. Annuals of Clinical Psychiatry, Vol. 6, No. 3.

Laws, R. D. (Ed.) (1989). Relapse prevention with sex offenders. New York, NY: Guilford Press.

Maletzky, B. (1997). Castration: A personal foul. Sexual Abuse: A Journal of Research and Treatment, 9(1), 1-5.

Maletzky, B. (1991). Treating the sexual offender. Newbury Park, CA: Sage Publications, Inc.

Marks, I. M. (1981a). Cure and care of neuroses. New York, N.Y.: John Wiley

Marshall, W. L., Laws, D. R., Barbaree, H. E. (Eds.) (1990) Handbook of sexual assault: Issues, theories, and treatment of the offender. New York, N. Y.: Plenum Press.

Matson, S., Lieb, R. (1996, Nov.) Community notification in Washington State: 1996 survey of law enforcement. Washington State Institute for Public Policy.

Money, J., Bennett, R.G. (1981). Post-adolescent paraphilic sex offenders: Antiandrogenic and counseling therapy follow-up. International Journal of Mental Health, Vol. 10, 122-133.

National Center for Missing & Exploited Children. (1998, Sept.) Model state sex-offender policy.

Ogloff, J. R. P., Wong, S., Greenwood, A. (1990). Treating criminal psychopaths in a therapeutic community program. Behavioral Sciences and the Law, Vol. 8, 181-190.

PAVE (1995) Feelings frequently felt by assault victims. Volunteer Manual, Chapter 5, 14-18.

Paykel, E.S. (1979, June). Sexual offender research. Paper presented to the Society for Psychotherapy Research, Oxford.

Perkins, C., Klaus, P. (1996) Criminal victimization 1994. Bureau of Justice Statistics, April 1996. 6-7.

Rice, M. E. (1997, Apr.) Violent offender research and implications for the criminal justice system. American Psychologist, Vol. 52. No. 4, 414-423.

Ross, Jonathan E. (1996). Handout, New Hope, Inc.

Ross, Jonathan E. (1994). Handout, New Hope, Inc.

Ross, Jonathan E. (1992). Handout, New Hope, Inc.

Rutland Department of Probation. (1999). Handout.

VTPSA (1991) Worksheet #10a: Example of lapses. Southwest Regional Correctional Facility Treatment Manual, 52.

Washington State Department of Corrections. (1997). Law enforcement guidelines for sex offender community notification meetings.

Wincze, J.P., Bansal, S., & Malamud, M. (1986). Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation, and nocturnal penile tumescence in male sex offenders. Archives of Sexual Behavior, Vol. 15, 293-305.

Zbytovsky, M., Zapletalek, M. (1979). Cyproterone acetate in the therapy of sexual deviations. Acta Nervosa






Chapter 1 Chapter 2 Chapter 2a Chapter 2B
Chapter 3 Chapter 4 Bibliography Addendums